Stress ulcer prophylaxis in the intensive care unit

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Pharmacology

Background:

• Stress ulcer prophylaxis (SUP) is a common practice for critically ill patients in intensive care units (ICUs).
• Gastrointestinal bleeding (GIB) is a potential complication in this patient population.
• The established benefits and risks of SUP require ongoing evaluation.

Purpose of the Study:

• To review current evidence on the efficacy and safety of SUP in ICU patients.
• To analyze the prevalence of GIB and identify risk factors.
• To assess the benefit-harm balance of SUP.

Main Methods:

• Systematic review of existing literature on SUP in critically ill patients.
• Analysis of data on GIB prevalence and associated risk factors.
• Evaluation of studies comparing SUP with placebo or no prophylaxis.

Main Results:

• Overt GIB occurs in approximately 5% of critically ill patients.
• Indications for SUP are inconsistent, despite identified risk factors.
• SUP is frequently administered, often using proton pump inhibitors, but evidence for its benefit is limited.
• Data indicate potential risks associated with SUP, including nosocomial infections and cardiovascular events.

Conclusions:

• GIB prevalence in ICUs is low, with ambiguous prognostic significance.
• Widespread use of SUP contrasts with a lack of robust evidence for its benefits.
• The benefit-harm profile of SUP remains unclear, necessitating further high-quality research.
• Clinical equipoise exists regarding the routine use of SUP in critically ill patients.